Dong‐Wan Kim
Seoul National University(KR)Korea University(KR)New Generation University College(ET)Seoul National University Hospital(KR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Gastric Cancer Management and Outcomes, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial(2015)6,477 cited
- → Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer(2017)2,413 cited
- → Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes(2006)1,848 cited
- → Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study(2012)1,275 cited
- → First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer(2020)1,028 cited
- → Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib(2005)775 cited